Leukotrienes are chemicals your body releases when you breathe in an allergen (such as pollen). Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.You should not use montelukast if you are allergic to it.To make sure montelukast is safe for you, tell your doctor if you have:Montelukast is not expected to be harmful to an unborn baby. Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. Was ist SINGULAIR? Singulair (montelukast) and other leukotriene modifiers can be used as an alternative therapy for the treatment of mild persistent asthma and adjunctive therapy in combination with inhaled steroids. Read the medication guide or patient instructions provided with each medication. If you are using the chewable tablets, chew them thoroughly before swallowing. ©2020 WebMD, Inc. All rights reserved.What are the possible side effects of montelukast (Singulair)?What is the most important information I should know about montelukast (Singulair)?What should I discuss with my healthcare provider before taking montelukast (Singulair)?What should I avoid while taking montelukast (Singulair)?What other drugs will affect montelukast (Singulair)? What should I discuss with my healthcare provider before taking montelukast (Singulair)? What Are Side Effects Associated with Using Montelukast?
Paediatric population. The safety and efficacy of Singulair 10 mg film-coated tablets in … Vielleicht möchten Sie diese später nochmals lesen.Wenn Sie weitere Fragen haben, wenden Sie sich an Ihren Arzt oder Apotheker.Dieses Arzneimittel wurde Ihnen persönlich verschrieben. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Dies gilt auch für Nebenwirkungen, die nicht in dieser Packungsbeilage angegeben sind.Sie können Nebenwirkungen auch direkt über „Bundesinstitut für Arzneimittel und Medizinprodukte, Bewahren Sie dieses Arzneimittel für Kinder unzugänglich auf.Sie dürfen dieses Arzneimittel nach dem auf dem Blister nach „Verw.
Es kann anderen Menschen schaden, auch wenn diese die gleichen Beschwerden haben wie Sie.Wenn Sie Nebenwirkungen bemerken, wenden Sie sich an Ihren Arzt oder Apotheker. Singulair is great at its job, but you might be wondering about its side effects.
It is generally less preferred for this use than inhaled corticosteroids. Tell your doctor if you are Follow all directions on your prescription label. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy.
1.
Führen Sie immer Ihre Notfallmedikation zur Inhalation für Asthmaanfälle mit sich.Es ist wichtig, alle Asthmamedikamente einzunehmen, die der behandelnde Arzt verordnet hat.
Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. It is generally less preferred for this use than inhaled corticosteroids. Over-the-counter antihistamine medication is an alternative to Singulair for mild allergy symptoms. Montelukast is a leukotriene (loo-koe-TRY-een) inhibitor. Common side effects include abdominal pain, cough, and headache.Montelukast was approved for medical use in the United States in 1998.Montelukast is used for a number of conditions including Montelukast is usually taken once a day with or without food.In 2019 and 2020, concerns for neuropsychiatric reactions were added to the label in the United Kingdom and United States where the most frequently suspected were nightmares, depression, insomnia (may affect between 1 in 100 to 1 in 1,000 people taking montelukast); aggression, anxiety and abnormal behaviour or changes in behaviour (may affect between 1 in 1,000 to 1 in 10,000 people taking montelukast).In September 2019, the Pediatric Advisory Committee and the Drug Safety and Risk Management Advisory Committee met to discuss a pediatric-focused safety review of neuropsychiatric events with montelukast.In March 2020, the FDA required a boxed warning for montelukast to strengthen an existing warning about the risk of neuropsychiatric events associated with the drug in the wake of an increase in case reporting of neuropsychiatric events around the time of the initial communications about the concern from FDA in 2008.In the FDA's self-conducted data analysis in comparison to their received case reports which were dependent on people's self-claims, the propensity of developing neuropsychiatric disorders after montelukast use does not outpace that of inhaled corticosteroids; and there were no statistically significant risks of new-onset neuropsychiatric disorders among males, females, patients 12 years and older, patients with a psychiatric history, or after the 2008 FDA communication and prescribing information changes that first publicized the concern.Montelukast has very few drug-drug interactions.